Literature DB >> 17004715

Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Synthesis, pharmacological, and molecular modeling studies.

Vittoria Colotta1, Daniela Catarzi, Flavia Varano, Ombretta Lenzi, Guido Filacchioni, Chiara Costagli, Alessandro Galli, Carla Ghelardini, Nicoletta Galeotti, Paola Gratteri, Jacopo Sgrignani, Francesca Deflorian, Stefano Moro.   

Abstract

In this paper, the study of new 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione derivatives, designed as AMPA and kainate (KA) receptor antagonists, is reported. Some derivatives bear different carboxy-containing alkyl chains on the 3-hydroxy group, while various heterocyclic rings or amide moieties are present at the 6-position of other compounds. Binding data at Gly/NMDA, AMPA, and high-affinity KA receptors showed that the presence of the free 3-hydroxy group is of paramount importance for a good affinity at all three investigated receptors, while introduction of some 6-heterocyclic moieties yielded AMPA-selective antagonists. The most significant result was the finding of the 6-(2-carboxybenzoylamino)-3-hydroxy-1H-quinazolin-2,4-dione 12, which possesses good affinity for high-affinity and low-affinity KA receptors (Ki=0.62 microM and 1.6 microM, respectively), as well as good selectivity. To rationalize the trend of affinities of the reported derivatives, an intensive molecular modeling study was carried out by docking compounds to models of the Gly/NMDA, AMPA, and KA receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17004715     DOI: 10.1021/jm0604880

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Synthesis and biological evaluation of cationic fullerene quinazolinone conjugates and their binding mode with modeled Mycobacterium tuberculosis hypoxanthine-guanine phosphoribosyltransferase enzyme.

Authors:  Manishkumar B Patel; Sivakumar Prasanth Kumar; Nikunj N Valand; Yogesh T Jasrai; Shobhana K Menon
Journal:  J Mol Model       Date:  2013-04-30       Impact factor: 1.810

2.  Ab initio studies of receptor interactions with AMPA ((S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl) propionic acid) and kainic acid (2S-(2 alpha, 3 beta, 4 beta))-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid.

Authors:  Elise Champeil; Gloria Proni; Danielle Sapse
Journal:  J Mol Model       Date:  2009-02-21       Impact factor: 1.810

3.  Quinazoline-2,4(1H, 3H)-diones inhibit the growth of multiple human tumor cell lines.

Authors:  Xiaoli Zhou; Xilei Xie; Gang Liu
Journal:  Mol Divers       Date:  2013-01-26       Impact factor: 2.943

4.  A new synthetic route to original sulfonamide derivatives in 2-trichloromethylquinazoline series: a structure-activity relationship study of antiplasmodial activity.

Authors:  Nicolas Primas; Pierre Verhaeghe; Anita Cohen; Charline Kieffer; Aurélien Dumètre; Sébastien Hutter; Sylvain Rault; Pascal Rathelot; Nadine Azas; Patrice Vanelle
Journal:  Molecules       Date:  2012-07-05       Impact factor: 4.411

5.  First discovery of novel 3-hydroxy-quinazoline-2,4(1H,3H)-diones as specific anti-vaccinia and adenovirus agents via 'privileged scaffold' refining approach.

Authors:  Dongwei Kang; Heng Zhang; Zhongxia Zhou; Boshi Huang; Lieve Naesens; Peng Zhan; Xinyong Liu
Journal:  Bioorg Med Chem Lett       Date:  2016-09-29       Impact factor: 2.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.